共 34 条
Integrated Analysis of Multiple Microarray Datasets Identifies a Reproducible Survival Predictor in Ovarian Cancer
被引:26
作者:
Konstantinopoulos, Panagiotis A.
[1
]
Cannistra, Stephen A.
[1
]
Fountzilas, Helen
[1
]
Culhane, Aedin
[2
]
Pillay, Kamana
[1
]
Rueda, Bo
[3
]
Cramer, Daniel
[4
]
Seiden, Michael
[5
]
Birrer, Michael
[6
]
Coukos, George
[7
]
Zhang, Lin
[7
]
Quackenbush, John
[2
,8
]
Spentzos, Dimitrios
[1
]
机构:
[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Dept Med,Sch Med, Boston, MA 02215 USA
[2] Harvard Univ, Dept Biostat & Computat Biol, Dana Farber Canc Inst, Dept Biostat,Sch Publ Hlth, Boston, MA 02215 USA
[3] Harvard Univ, Dept Obstet Gynecol & Reprod Biol, Massachusetts Gen Hosp, Sch Med, Boston, MA 02215 USA
[4] Harvard Univ, Dept Obstet Gynecol & Reprod Biol, Brigham & Womens Hosp, Sch Med, Boston, MA 02215 USA
[5] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[6] Harvard Univ, Div Gynecol Med Oncol, Massachusetts Gen Hosp, Sch Med, Boston, MA 02215 USA
[7] Univ Penn, Dept Gynecol Oncol, Philadelphia, PA 19104 USA
[8] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA
来源:
关键词:
GENE-EXPRESSION;
GENOMIC SIGNATURES;
STAGE-III;
PACLITAXEL;
CISPLATIN;
PATTERNS;
PATHWAY;
CELL;
CARBOPLATIN;
CARCINOMA;
D O I:
10.1371/journal.pone.0018202
中图分类号:
O [数理科学和化学];
P [天文学、地球科学];
Q [生物科学];
N [自然科学总论];
学科分类号:
07 ;
0710 ;
09 ;
摘要:
Background: Public data integration may help overcome challenges in clinical implementation of microarray profiles. We integrated several ovarian cancer datasets to identify a reproducible predictor of survival. Methodology/Principal Findings: Four microarray datasets from different institutions comprising 265 advanced stage tumors were uniformly reprocessed into a single training dataset, also adjusting for inter-laboratory variation ("batcheffect"). Supervised principal component survival analysis was employed to identify prognostic models. Models were independently validated in a 61-patient cohort using a custom array genechip and a publicly available 229-array dataset. Molecular correspondence of high-and low-risk outcome groups between training and validation datasets was demonstrated using Subclass Mapping. Previously established molecular phenotypes in the 2(nd) validation set were correlated with high and low-risk outcome groups. Functional representational and pathway analysis was used to explore gene networks associated with high and low risk phenotypes. A 19-gene model showed optimal performance in the training set (median OS 31 and 78 months, p < 0.01), 1(st) validation set (median OS 32 months versus not-yet-reached, p=0.026) and 2(nd) validation set (median OS 43 versus 61 months, p=0.013) maintaining independent prognostic power in multivariate analysis. There was strong molecular correspondence of the respective high-and low-risk tumors between training and 1(st) validation set. Low and high-risk tumors were enriched for favorable and unfavorable molecular subtypes and pathways, previously defined in the public 2(nd) validation set. Conclusions/Significance: Integration of previously generated cancer microarray datasets may lead to robust and widely applicable survival predictors. These predictors are not simply a compilation of prognostic genes but appear to track true molecular phenotypes of good-and poor-outcome.
引用
收藏
页数:12
相关论文